Empirical Finance LLC Has $824,000 Stake in Colgate-Palmolive (NYSE:CL)

Empirical Finance LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 16.6% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 10,125 shares of the company’s stock after buying an additional 1,440 shares during the period. Empirical Finance LLC’s holdings in Colgate-Palmolive were worth $824,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Pitcairn Co. raised its holdings in Colgate-Palmolive by 2.2% in the 1st quarter. Pitcairn Co. now owns 5,808 shares of the company’s stock valued at $458,000 after acquiring an additional 123 shares in the last quarter. Colonial Trust Advisors raised its stake in shares of Colgate-Palmolive by 1.0% in the first quarter. Colonial Trust Advisors now owns 12,195 shares of the company’s stock valued at $961,000 after purchasing an additional 125 shares in the last quarter. Baker Tilly Wealth Management LLC boosted its stake in Colgate-Palmolive by 1.5% during the second quarter. Baker Tilly Wealth Management LLC now owns 8,406 shares of the company’s stock worth $684,000 after buying an additional 127 shares in the last quarter. Horan Securities Inc. increased its holdings in Colgate-Palmolive by 60.1% in the 2nd quarter. Horan Securities Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 128 shares during the period. Finally, Bull Street Advisors LLC raised its stake in shares of Colgate-Palmolive by 1.5% in the 1st quarter. Bull Street Advisors LLC now owns 8,907 shares of the company’s stock valued at $702,000 after buying an additional 130 shares in the last quarter. 76.28% of the stock is currently owned by institutional investors and hedge funds.

In other news, insider Jennifer Daniels sold 20,290 shares of the stock in a transaction on Thursday, August 5th. The stock was sold at an average price of $79.11, for a total transaction of $1,605,141.90. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Lorrie M. Norrington sold 1,898 shares of the business’s stock in a transaction on Wednesday, August 4th. The stock was sold at an average price of $78.02, for a total value of $148,081.96. Following the transaction, the director now directly owns 24,602 shares of the company’s stock, valued at approximately $1,919,448.04. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

A number of brokerages have commented on CL. UBS Group started coverage on shares of Colgate-Palmolive in a research note on Wednesday, June 23rd. They set a “buy” rating and a $95.00 price target for the company. Evercore ISI reiterated a “buy” rating and set a $95.00 target price on shares of Colgate-Palmolive in a research report on Sunday, June 20th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Colgate-Palmolive from $86.00 to $84.00 and set a “hold” rating on the stock in a research note on Monday, August 2nd. Finally, Credit Suisse Group raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and raised their price target for the company from $80.00 to $95.00 in a report on Wednesday, June 9th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $85.54.

Shares of NYSE CL opened at $77.30 on Wednesday. The company has a current ratio of 1.11, a quick ratio of 0.70 and a debt-to-equity ratio of 9.22. The firm has a market cap of $65.20 billion, a PE ratio of 24.23, a PEG ratio of 3.98 and a beta of 0.60. Colgate-Palmolive has a 1-year low of $74.14 and a 1-year high of $86.41. The company has a fifty day moving average price of $79.95 and a 200 day moving average price of $80.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Thursday, July 29th. The company reported $0.80 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.80. Colgate-Palmolive had a net margin of 15.98% and a return on equity of 293.48%. The company had revenue of $4.26 billion for the quarter, compared to the consensus estimate of $4.24 billion. During the same period last year, the company earned $0.74 earnings per share. The firm’s revenue was up 9.3% compared to the same quarter last year. Equities research analysts forecast that Colgate-Palmolive will post 3.23 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, November 15th. Investors of record on Thursday, October 21st will be paid a $0.45 dividend. The ex-dividend date of this dividend is Wednesday, October 20th. This represents a $1.80 annualized dividend and a dividend yield of 2.33%. Colgate-Palmolive’s dividend payout ratio is presently 58.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

Featured Story: What are the advantages to having securities held in street name?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.